The U.S. Food and Drug Administration has granted market approval to EarlySense of Waltham, Mass., for its chair sensor solution.

The chair sensor, which continuously monitors patient’s heart rate, respiratory rate and movement, was recently evaluated at Coffee Regional Medical Center in Douglas, Ga., where it successfully enabled the clinical team to proactively respond to early signs of patient deterioration and to prevent patient falls. EarlySense says this is the first contact-free sensor for vital sign monitoring in a chair.

"Clinicians have long known that ambulating patients from bed to chair improves healing, reduces the risk of complications, and shortens length of stay," said the company in a statement. "Moving around in an upright position appears to be of most benefit in the early post-operative period and to improve lung function and reduce potential pulmonary complications. But to date there was not automatic contact-free solution for keeping patients safe in their chairs."

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access